measurement. To determine the content of the amines on the silica surfaces, elemental analysis was conducted using Vario EL Ш.
Preparation of ADS-GO, CA-GO and NER-GO NER-GO was prepared by similar procedure described in elsewhere. 1 In detail, 5 mg of amino-S-MPS was incubated with 1.5 mL of 25 mg/mL GO solution in 0.1 M sodium phosphate buffer (PB, pH 7.0) under 200 rpm shaking for 2 hr. Then, the 5 sample was centrifuged down at 10000 rpm for 10 min, and the supernatant was decanted. After GO adsorption, GA solution (0.5% in 0.1 M PB, pH 7.0) was added and incubated for 3 hr. Then, 0.1 M Tris-HCl buffer (pH 8.0) was added to cap un-reacted aldehyde groups. The sample was excessively washed with 0.1 M PB (pH 7.0), and stored at 4°C before use. As control samples, ADS-GO and CA-GO were prepared. For preparation of simply adsorbed GO in amino-S-MPS (ADS-GO), all 10 procedures for NER-GO were duplicated except the GA treatment step. In other words, 0.1 M PB (pH 7.0) was added instead of GA solution. Covalently attached GO on amino-S-MPS (CA-GO) was prepared by treating amino-S-MPS with GA (0.1% in 0.1 M PB pH 7.0) before the incubation in the GO solution.
Activity and stability of ADS-GO, CA-GO and NER-GO The activities of ADS-GO, CA-GO and 15 NER-GO were measured by a conventional GO assay. 100 µL of each sample was reacted with 890 µL of reaction cocktail (0.17 mM o-dianisidine and 1.72% (w/v) D-glucose) and 10 µL of 600 U/mL of peroxidase solution under shaking (250 rpm). 100 µL of mixture was withdrawn every 3 min for 15 min, and mixed with 900 µL of 0.1 M PB (pH 7.0). The absorbance 500 nm (A500) was measured by using UV spectrophotometer (Shimadzu, UV-2450, Kyoto, Japan). The activity was calculated with 20 absorbance increase at 500 nm per min (A500/min), and further normalized per 1 mg of amino-S-MPS.
The stabilities of ADS-GO, CA-GO and NER-GO were checked under continuous shaking (200 rpm) at room temperature for 26 days. The stabilities of the samples were checked by measuring the residual enzyme activity of each sample at the specific time point, and the relative activity was calculated from the ratio of residual activity to the initial activity of each sample.
Preparation of antibody-conjugated GO For preparation of antibody-conjugated GO, oxidized GO was conjugated with anti-hIgG antibody by reductive amination coupling. 2 Briefly, 10 mg of GO was dissolved with 5 mg of sodium meta-periodate in 1 mL of 0.1 M PB (pH 7.0), and incubated in the dark at room temperature for 30 min. The sample was purified using desalting column (PD-10, GE Healthcare, USA) by using 0.1 M PB (pH 7.0) as an elution buffer. After desalting, the sample was 5 concentrated to 5.0 mg/mL of GO by using a centrifugal filter (Centricon YM 100, Millipore, USA) by exchanging the buffer to 0.2 M sodium bicarbonate buffer (pH 9.6). The oxidized GO was mixed with anti-hIgG antibody (Fc specific, 1 mg/mL in 0.2 M sodium bicarbonate buffer, pH 9.6) in a 2:1 molar ratio of GO to anti-hIgG antibody, and incubated in a dark for 2 hr. Immunoassay using antibody-conjugated NER-GO and antibody-conjugated GO The sandwich immunoassay was performed by using antibody-conjugated NER-GO and antibody-conjugated GO for the detection of hIgG as a model analyte. 25 μL of anti-hIgG antibody solution (Fab specific, 10 5 μg/mL in coating buffer) was added to each well, and incubated at 4°C for overnight. After decanting the unbound antibody solution, wells were blocked by addition of 100 μL of blocking buffer and incubated at room temperature for 1 h. After blocking buffer was removed, it was washed 5 times with 150 μL of washing buffer. 50 μL of hIgG solutions (0 to 10 μg/mL in 0.05% PBST) were added to each well and incubated at 37°C for 1 h. After the incubation, unreacted hIgG solutions were removed, 10 and 5-time washings were done with 150 μL of washing buffer. 50 μL of antibody-conjugated NER-GO (100 μg/mL in 0.05% PBST) were added to each well, and incubated at 37°C for 30 min. Unbound antibody-conjugated NER-GO was excessively washed with 150 μL of washing buffer. After washing, 50 μL of substrate solution (100 μM Amplex red, 0.2 U/mL HRP, and 100 mM glucose in 50 mM PB (pH 7.4)) was added in each well, and the absorbance was measured at 570 nm every 5 min under 15 shaking. As a control experiment, antibody-conjugated GO was used instead of antibody-conjugated NER-GO. The input antibody concentration to each well was controlled as the same in both antibodyconjugated GO and antibody-conjugated NER-GO (1 μg/mL per well). To check the specificity of hIgG detection by using antibody-conjugated NER-GO, 1 μg/mL of rIgG or mIgG were used as a negative control. Every experiment was performed in triplicates, and errors were calculated by the 20 standard deviation. The limit of detection (LOD) was estimated by the hIgG concentration, which produces a signal greater than the sum of the averaged blank signal and three times their standard deviation. The coefficient of variations (CV) was calculated by the percentage ratio of standard deviation to the averaged signal. Figure S1 . The SEM images of S-MPS (a) and amorphous silica (b).
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